Zacks Research Flags Four Medical Stocks Poised for Q2 Earnings Beats

Analyst
โดย Zacks Investment Research·Read original
Summary · why it matters

Zacks Investment Research has identified four medical-sector companies with the right setup to beat second-quarter earnings expectations. The picks are CVS Health, Cardinal Health, Humana, and ACADIA Pharmaceuticals, each combining a positive Earnings ESP with a Zacks Rank of 1 or 2. Humana carries a Zacks Rank of 1 and an Earnings ESP of plus 1.71 percent, with consensus revenue estimates of 40.65 billion dollars implying 25.5 percent growth. CVS Health holds a Zacks Rank of 2 and an Earnings ESP of plus 1.42 percent, with consensus revenue of 100.18 billion dollars. Cardinal Health also has a Zacks Rank of 2 and an Earnings ESP of plus 1.24 percent, with fiscal fourth-quarter revenue pegged at 65.61 billion dollars. ACADIA Pharmaceuticals rounds out the list with a Zacks Rank of 2 and an Earnings ESP of plus 25.00 percent, driven by expected growth from Daybue and Nuplazid.

Impact on stocks 4

Health Care▲ · 2 stocks
Cardinal Health Inc
CAH
▲ PositiveCapitalrelevance

Zacks identifies Cardinal Health as having a positive Earnings ESP and strong Rank, indicating likely earnings beat.

CVS Health Corp
CVS
▲ PositiveCapitalrelevance

Zacks identifies CVS Health as having a positive Earnings ESP and strong Rank, indicating likely earnings beat.

Biotech & Genomic Medicine▲ · 1 stocks
ACADIA Pharmaceuticals Inc
ACAD
▲ PositiveCapitalrelevance

Zacks identifies ACADIA as having a positive Earnings ESP of 25% and strong Rank, indicating likely earnings beat.

Aging Population▲ · 1 stocks
Humana Inc
HUM
▲ PositiveCapitalrelevance

Zacks identifies Humana as having a positive Earnings ESP and strong Rank, indicating likely earnings beat.

© 2026 MarketDXNews